نتائج البحث - "Ron Paquette"

1

Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY

المؤلفون: Srikanth Gajavelli, Loretta A. Williams, Mauricette Michallet, Ron Paquette, Irene DeGutis, Ruediger Hehlmann, Jorge E. Cortes, Teresa Zyczynski, Michael J. Mauro, Ginny P Sen, Carlo Gambacorti-Passerini, Bengt Simonsson, Stuart L. Goldberg

المساهمون: Hehlmann, R, Cortes, J, Zyczynski, T, Gambacorti-Passerini, C, Goldberg, S, Mauro, M, Michallet, M, Simonsson, B, Williams, L, Gajavelli, S, Degutis, I, Sen, G, Paquette, R

المصدر: American Journal of Hematology

مصطلحات موضوعية: Male, medicine.medical_specialty, Myeloid, medicine.drug_class, Respiratory Tract Diseases, Dasatinib, Antineoplastic Agents, Drug Administration Schedule, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Intolerances, MED/15 - MALATTIE DEL SANGUE, Internal medicine, Humans, Medicine, Molecular Targeted Therapy, Musculoskeletal Diseases, Prospective Studies, Hematologi, Prospective cohort study, Protein Kinase Inhibitors, Research Articles, Aged, Cancer och onkologi, Drug Substitution, business.industry, Disease Management, Myeloid leukemia, Imatinib, Hematology, Hematologic Diseases, United States, respiratory tract diseases, Europe, Pyrimidines, medicine.anatomical_structure, Nilotinib, Drug Resistance, Neoplasm, Cancer and Oncology, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Imatinib Mesylate, Female, business, Research Article, 030215 immunology, medicine.drug

وصف الملف: application/pdf; ELETTRONICO

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf757800bc84051386bb54526e10caf5
https://doi.org/10.1002/ajh.25306

View record at Wiley

2

First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice : SIMPLICITY

المؤلفون: Pascale Cony-Makhoul, Carlo Gambacorti-Passerini, Elza Lomaia, Ruediger Hehlmann, Bengt Simonsson, Michael J. Mauro, Aart Beeker, Mauricette Michallet, Eduardo Olavarria, Stuart L. Goldberg, Richard M. Hansen, Elisabetta Abruzzese, David Andorsky, Aimee Foreman, Jorge E. Cortes, Teresa Zyczynski, H. Jean Khoury, Ron Paquette

المساهمون: Goldberg, S, Cortes, J, Gambacorti-Passerini, C, Hehlmann, R, Khoury, H, Michallet, M, Paquette, R, Simonsson, B, Zyczynski, T, Foreman, A, Abruzzese, E, Andorsky, D, Beeker, A, Cony-Makhoul, P, Hansen, R, Lomaia, E, Olavarria, E, Mauro, M

المصدر: American Journal of Hematology

مصطلحات موضوعية: Oncology, Adult, Male, United State, medicine.medical_specialty, Pediatrics, Myeloid, media_common.quotation_subject, Biopsy, Protein Kinase Inhibitor, Comorbidity, Follow-Up Studie, 03 medical and health sciences, 0302 clinical medicine, Bone Marrow, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Routine clinical practice, Simplicity, Hematologi, Practice Patterns, Physicians', Protein Kinase Inhibitors, Selection (genetic algorithm), Research Articles, In Situ Hybridization, Fluorescence, media_common, Aged, Hematology, business.industry, Myeloid leukemia, Middle Aged, medicine.disease, United States, Europe, Leukemia, medicine.anatomical_structure, Treatment Outcome, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Female, Bone marrow, business, 030215 immunology, Follow-Up Studies, Research Article, Human

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ad2e6a3c4d932c21654f5abea0ec46
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-339738

3

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia

المساهمون: Pediatrics

المصدر: Blood, 112(4), 1005-1012. American Society of Hematology

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, medicine.drug_class, Immunology, Dasatinib, Drug Evaluation, Preclinical, Pharmacology, Gene mutation, Spinal Puncture, Biochemistry, Tyrosine-kinase inhibitor, Central Nervous System Neoplasms, Mice, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, Animals, Humans, Medicine, Child, Survival rate, Aged, Hematology, business.industry, Remission Induction, Imatinib, Cell Biology, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, medicine.disease, Tumor Burden, Survival Rate, Disease Models, Animal, Thiazoles, Leukemia, Pyrimidines, Treatment Outcome, Imatinib mesylate, Blood-Brain Barrier, Cytogenetic Analysis, Cancer research, Female, Drug Monitoring, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ceedc511a7965b3b88d994b5223378f
https://pure.eur.nl/en/publications/13a0aaaf-c56a-4ff5-893d-cc0e4742a4ad

4

Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification

المؤلفون: Katharine Ellwood, Charles L. Sawyers, Nicholas C. Hsu, Mansoor Mohammed, P. Nagesh Rao, Ron Paquette, Mercedes E. Gorre

المصدر: Science. 293:876-880

مصطلحات موضوعية: Molecular Sequence Data, Fusion Proteins, bcr-abl, Antineoplastic Agents, Drug resistance, Genes, abl, Biology, Piperazines, Cell Line, chemistry.chemical_compound, Recurrence, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Proto-Oncogene Proteins, hemic and lymphatic diseases, Gene duplication, Omacetaxine mepesuccinate, medicine, Humans, Point Mutation, Philadelphia Chromosome, Amino Acid Sequence, Phosphorylation, Proto-Oncogene Proteins c-abl, Multidisciplinary, ABL, Base Sequence, Gene Amplification, Myeloid leukemia, Hydrogen Bonding, Proto-Oncogene Proteins c-crk, Protein Structure, Tertiary, Pyrimidines, Imatinib mesylate, Amino Acid Substitution, Nilotinib, chemistry, Drug Resistance, Neoplasm, Benzamides, Imatinib Mesylate, Cancer research, Signal transduction, Blast Crisis, Signal Transduction, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4cf52ed46f9e61dd9406374af507a84
https://doi.org/10.1126/science.1062538

Find this article in full text from ProQuest

5

Tyrosine Kinase Inhibitor (TKI) Switching Patterns during the First 12 Months in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice

المؤلفون: Aimee Foreman, Carlo Gambacorti, Mauricette Michallet, Stuart L. Goldberg, Rüdiger Hehlmann, Ron Paquette, Bengt Simonsson, Yuanxin Rong, Jorge E. Cortes, Michael J. Mauro, Teresa Zyczynski, Aleksandra Zagorska, Brian Calimlim

المصدر: Blood. 128:937-937

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6e7b6e69b9408eb359d5bc9f3ca61a04
https://doi.org/10.1182/blood.v128.22.937.937

6

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia

المصدر: Experimental hematology. 40(11)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb9c6699320bbaf629e8586fe83b9e0
https://pubmed.ncbi.nlm.nih.gov/22842045

View record from ScienceDirect

Full Text via ClinicalKey

7

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

المؤلفون: Ron Paquette, Guillermo Garcia-Manero, Dietmar Berger, Hagop M. Kantarjian, Janet Franklin, Eunice S. Wang, Francis J. Giles, Janice Gabrilove, Kuolung Hu, Peter L. Greenberg

المصدر: Blood. 116(17)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90cb77375857a3809ec73348109abc15
https://pubmed.ncbi.nlm.nih.gov/20631375

8

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells

المؤلفون: Michael W. Deininger, Dietger Niederwieser, Byung Park, Douglas R. Smith, Michele Baccarani, Brian J. Druker, François Guilhot, Insa Gathmann, Thomas Fischer, Andreas Hochhaus, Richard Stone, John M. Goldman, Hagop M. Kantarjian, Jorge E. Cortes, Charlene So, Carlo Gambacorti-Passerini, Ron Paquette

المساهمون: Deininger, M, Cortes, J, Paquette, R, Park, B, Hochhaus, A, Baccarani, M, Stone, R, Fischer, T, Kantarjian, H, Niederwieser, D, GAMBACORTI PASSERINI, C, So, C, Gathmann, I, Goldman, J, Smith, D, Druker, B, Guilhot, F, Deininger MW, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M, Stone R, Fischer T, Kantarjian H, Niederwieser D, Gambacorti-Passerini C, So C, Gathmann I, Goldman JM, Smith D, Druker BJ, Guilhot F.

المصدر: Cancer. 110(7)

مصطلحات موضوعية: Oncology, Male, Cancer Research, Myeloid, Kaplan-Meier Estimate, Piperazines, hemic and lymphatic diseases, Treatment Failure, Aged, 80 and over, Myeloid leukemia, Middle Aged, Prognosis, Leukemia, medicine.anatomical_structure, Treatment Outcome, Benzamides, Cytogenetic Analysis, Imatinib Mesylate, Female, medicine.drug, Adult, medicine.medical_specialty, Neutropenia, Antineoplastic Agents, Philadelphia chromosome, Disease-Free Survival, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, chronic myeloid leukemia, Internal medicine, parasitic diseases, medicine, Humans, Aged, Chromosome Aberrations, Chi-Square Distribution, business.industry, Myelodysplastic syndromes, Cancer, Interferon-alpha, Imatinib, medicine.disease, Thrombocytopenia, Imatinib mesylate, Logistic Models, Pyrimidines, Myelodysplastic Syndromes, Chronic Disease, Cancer research, business, Follow-Up Studies